Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0002-6320-6255Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Mutsuki Kawabe, Sujuan Yang, Lorena I. Gomez Bolanos…·Abdullah A. Osman
This study shows that suppressing SPP1 improves cisplatin sensitivity and inhibits tumor invasion and metastasis in NRF2-hyperactivated cisplatin-resistant HNSCC.
Chenfei Huang, Shhyam Moorthy, Qiuli Li…·Mitchell J. Frederick
This study clarifies that NOTCH1 acts as a tumor suppressor in head and neck cancer, reducing cancer stem cells and improving prognosis, despite conflicting prior reports.
Pedram Yadollahi, Kelli A. McCord, Li Yang…·Vlad Constantin Sandulache
This paper identifies PI3K pathway activation in Nrf2-driven cisplatin-resistant HNSCC and shows that gedatolisib inhibits tumor growth and re-sensitizes cells to cisplatin.
Li Yang, Pedram Yadollahi, F. Essien…·Vlad Constantin Sandulache
This study shows cigarette smoke exposure drives aggressive head and neck cancer by altering oxidative stress response and immunity through Nrf2 activation and metabolic reprogramming.